Insider Transactions in Q3 2023 at Mirati Therapeutics, Inc. (MRTX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 08
2023
|
Jamie Christensen EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,388
-1.63%
|
$83,580
$35.63 P/Share
|
|
Sep 08
2023
|
Aaron Ondrey Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,412
+27.27%
|
$294,420
$35.66 P/Share
|
|
Aug 11
2023
|
Boxer Capital, LLC |
BUY
Open market or private purchase
|
Direct |
2,402,880
+27.29%
|
$64,877,760
$27.8 P/Share
|
|
Aug 11
2023
|
Boxer Capital, LLC |
BUY
Open market or private purchase
|
Indirect |
115,066
+16.66%
|
$3,106,782
$27.8 P/Share
|
|
Aug 11
2023
|
Faheem Hasnain |
BUY
Open market or private purchase
|
Indirect |
10,791
+50.0%
|
$291,357
$27.8 P/Share
|
|
Aug 09
2023
|
Charles M Baum Founder, President, and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
54,054
+19.21%
|
$1,999,998
$37.0 P/Share
|
|
Aug 09
2023
|
Laurie Stelzer Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,297
+17.89%
|
$824,989
$37.0 P/Share
|
|
Aug 09
2023
|
Alan B. Sandler Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,297
+26.36%
|
$824,989
$37.0 P/Share
|
|
Aug 09
2023
|
Jamie Christensen EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,297
+13.22%
|
$824,989
$37.0 P/Share
|
|
Aug 09
2023
|
John B Moriarty Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,297
+23.73%
|
$824,989
$37.0 P/Share
|
|
Aug 09
2023
|
Benjamin Hickey EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,297
+17.39%
|
$824,989
$37.0 P/Share
|